claim
The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend measuring high-sensitivity C-reactive protein (hs-CRP) when treatment decisions are uncertain based on global risk scoring.
Authors
Sources
- EBM Tools for Practice: Best Biomarkers for Inflammation www.lipid.org via serper